Add to Google Reader or Homepage

Subscribe in NewsGator Online

Subscribe in Bloglines

Notices

  • Copyright©2008-2009, F-D-C Reports, Inc. and Windhover Information Inc. All rights reserved.

« Market in Focus: Surgical Sealants and Glues | Main

June 25, 2009

TransEnterix: Managing Revolutions in Surgery

Article preview reprinted from IN VIVO -  May, 2009 

Minimally invasive surgery, performed through a number of ports to create access and enable visualization, manipulation, and dissection, promised to revolutionize surgical techniques two decades ago, but ultimately fell short of changing the way surgeons perform the majority of surgical cases. Now, the next generation in minimally invasive surgery sees single-port surgeries and natural orifice transluminal endoscopic surgeries (NOTES) gaining momentum. TransEnterix aims to operate in both cases, with a novel approach that not only allows surgeons greater dexterity in performing complex procedures, but also enables them to do surgical cases through a single access port, using the body's umbilicus. Read more...

TransEnterix: Managing Revolutions in Surgery

Article preview reprinted from IN VIVO -  May, 2009 

Minimally invasive surgery, performed through a number of ports to create access and enable visualization, manipulation, and dissection, promised to revolutionize surgical techniques two decades ago, but ultimately fell short of changing the way surgeons perform the majority of surgical cases.

Part of the problem: surgeons were uncomfortable with the devices developed to enable more complex procedures. TransEnterix's solution: surgical tools that adapt the flexible catheter technology behind interventional cardiology to general surgery.

TransEnterix's novel approach not only allows surgeons greater dexterity in performing complex procedures, but also enables them to do surgical cases through a single access port, using the body's umbilicus.

So-called single-port surgery has its skeptics, but it's gaining momentum. The question for TransEnterix: how will single-port surgery play out against the surgery's newest technique--natural orifice transluminal endoscopic surgery, or NOTES?

For all of the change that minimally invasive approaches brought to surgery two decades ago, the MIS revolution has fallen something short of complete. While conversion to MIS or laparoscopic techniques was rapid and remains at nearly 100% in gall bladder removal (cholecystectomy), other procedures have taken longer to convert and have come nowhere near the same rate of penetration—thus procedures such as bowel resection and appendectomy are only performed laparoscopically about 50% of the time; in an area like cardiac surgery, penetration rates have stalled at much lower numbers.

- David Cassak

Purchase this article online  as a PDF and receive it immediately via email. Questions? Call (800) 332-2181. 100% Satisfaction Guaranteed. Subscribe to IN VIVO.

Companies mentioned in this article:

Boston Scientific Corp.

Covidien Ltd.

Johnson & Johnson

Closure Medical Corp.

Cordis Corp.

Ethicon Endo-Surgery Inc.

SurgRx Inc.

MAKO Surgical Corp.

Olympus Corp.

Gyrus Group PLC

Stryker Corp.

SyneCor LLC

TransEnterix Inc.


IN VIVO delivers:

  • Revealing, in-depth coverage of your competitors' strategies
  • Incisive projections of future industry trends and their implications for your business
  • Expert analysis of key industry developments
  • Exclusive interviews with top industry executives and analysts
  • In-depth examination of dealmaking, marketing, R&D, regulatory, and finance strategies -- those that were successful and those that missed the mark

Subscribe to IN VIVO today!

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d83452f00669e20115715a4c36970b

Listed below are links to weblogs that reference TransEnterix: Managing Revolutions in Surgery :

Search Medical Devices Today


  • medicaldevicestoday.com

Medical Device Advertisements

Device Industry Announcements